“Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s95. https://doi.org/10.25251/skin.4.supp.95.